摘要
目的分析患有乙肝肝硬化且处于活动期的患者实施替比夫定联合阿德福韦酯的治疗效果。方法收集乙肝肝硬化且处于活动期的患者50例,实验组实施替比夫定联合阿德福韦酯治疗,对照组实施阿德福韦酯单独治疗。结果实验组肝功能各项指标比对照组高。结论使用替比夫定联合阿德福韦酯医治活动性乙肝肝硬化的效果较好,可以积极抑制病毒复制情况。
Objective To analyze the therapeutic effect of hepatitis B cirrhosis and in active stage in patients with the implementation of telbivudine and adefovir dipivoxil. Methods Collection of hepatitis B cirrhosis 50 patients with active stage,the experimental group implementation of telbivudine and adefovir dipivoxil treatment. The control group received adefovir dipivoxil treatment alone. Results The indexes of liver function in the experimental group were higher than those in the control group. Conclusion The use of telbivudine and adefovir dipivoxil in treatment of active hepatitis B cirrhosis effect is good,can be actively suppress viral replication.
出处
《中国卫生标准管理》
2016年第14期98-99,共2页
China Health Standard Management
关键词
替比夫定
阿德福韦酯
乙肝肝硬化
Telbivudine
Adefovir dipivoxil
Hepatitis B cirrhosis
